Reader View AI Reader View Lexeo Therapeutics shares surge 25% on interim data for LX2020 gene therapy www.investing.com · November 16, 2026 · 13:31 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link